Streptococcus Thermophilus
A primary yogurt starter bacterium (with Lactobacillus delbrueckii subsp. bulgaricus). Its standout evidence — endorsed by an EFSA health claim — is improving lactose digestion when consumed with live cultures in yogurt. As a standalone probiotic strain its evidence is thinner; most clinical benefits in antibiotic-associated diarrhoea, acute gastroenteritis, and NEC come from multi-strain blends where S. thermophilus is one of several organisms.
Quick decision guide
May help most
Adults with lactose maldigestion eating yogurt or fermented dairy; children on antibiotics (as part of a multi-strain probiotic blend); selected NICU protocols for preterm infants under neonatology care.
Common dosing range
≥10^8 CFU/g consumed in live yogurt for lactose digestion; multi-strain probiotic capsules typically supply 1–10 billion CFU/day, with S. thermophilus contributing part of that total.
When to expect effects
Immediate (within the meal) for lactose digestion; days to weeks for AAD prevention.
Watch out for
Generally safe in immunocompetent adults and children. Avoid live probiotic supplements (and unpasteurised yogurt) in immunocompromised, critically ill, and central-line patients due to rare invasive infections.
Evidence snapshot
What is it
Streptococcus thermophilus is a Gram-positive, facultatively anaerobic, homofermentative lactic acid bacterium and one of the two starter cultures (alongside Lactobacillus delbrueckii subsp. bulgaricus ) traditionally required by international standards to be present in yoghurt. It is one of the most economically important industrial dairy microorganisms and, although taxonomically grouped with the streptococci, is non-pathogenic and bears the Generally Recognised As Safe (GRAS) and EFSA Qualified Presumption of Safety (QPS) status. The species ferments lactose to lactic acid via the EMP pathway, expresses a beta-galactosidase that contributes to lactose digestion in the small intestine, and produces extracellular polysaccharides that contribute to yoghurt texture. It is widely used as a probiotic species in fermented dairy products, infant formulas, and capsule supplements, often in combination with bifidobacteria and other lactobacilli.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Lactose maldigestion / intolerance Strong Evidence | Significant reduction in breath hydrogen and lactose-intolerance symptoms vs milk or heat-killed yogurt | Adults and children with lactose maldigestion eating live-culture yogurt or kefir | Immediate — within the meal containing live yogurt |
Antibiotic-associated diarrhoea (AAD) prevention Good Evidence | AAD risk reduction ~55% in children with multi-strain probiotics that include S. thermophilus | Children prescribed broad-spectrum antibiotics, taking a multi-strain probiotic concurrently | Start probiotics with the first antibiotic dose; continue through and 1 week after the course |
Acute infectious diarrhoea in children Limited Evidence | ~1-day shorter duration of acute diarrhoea in some trials with multi-strain products containing S. thermophilus | Children with acute viral or mild bacterial gastroenteritis, alongside oral rehydration | Days within the diarrhoea episode |
Necrotising enterocolitis (NEC) prevention in preterm infants Limited Evidence | Reduction in NEC incidence in preterm infants with multi-strain probiotic protocols | Preterm infants in NICUs with established probiotic protocols under neonatology care | Reduction in NEC over the NICU admission period |
IBS / functional bowel symptoms in adults (general gut support) Mixed Evidence | Small and inconsistent symptom benefit in multi-strain trials; no clear single-strain S. thermophilus signal | Adults willing to trial a probiotic for 8 weeks and reassess — not S. thermophilus specifically | Not well established; 4–8 weeks if any effect is to emerge |
Lactose maldigestion / intolerance
- Effect
- Significant reduction in breath hydrogen and lactose-intolerance symptoms vs milk or heat-killed yogurt
- Best fit
- Adults and children with lactose maldigestion eating live-culture yogurt or kefir
- Time
- Immediate — within the meal containing live yogurt
Antibiotic-associated diarrhoea (AAD) prevention
- Effect
- AAD risk reduction ~55% in children with multi-strain probiotics that include S. thermophilus
- Best fit
- Children prescribed broad-spectrum antibiotics, taking a multi-strain probiotic concurrently
- Time
- Start probiotics with the first antibiotic dose; continue through and 1 week after the course
Acute infectious diarrhoea in children
- Effect
- ~1-day shorter duration of acute diarrhoea in some trials with multi-strain products containing S. thermophilus
- Best fit
- Children with acute viral or mild bacterial gastroenteritis, alongside oral rehydration
- Time
- Days within the diarrhoea episode
Necrotising enterocolitis (NEC) prevention in preterm infants
- Effect
- Reduction in NEC incidence in preterm infants with multi-strain probiotic protocols
- Best fit
- Preterm infants in NICUs with established probiotic protocols under neonatology care
- Time
- Reduction in NEC over the NICU admission period
IBS / functional bowel symptoms in adults (general gut support)
- Effect
- Small and inconsistent symptom benefit in multi-strain trials; no clear single-strain S. thermophilus signal
- Best fit
- Adults willing to trial a probiotic for 8 weeks and reassess — not S. thermophilus specifically
- Time
- Not well established; 4–8 weeks if any effect is to emerge
Evidence for 5 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Lactose maldigestion / intolerance
Supplement benefitThe marquee indication. Live cultures of S. thermophilus + L. bulgaricus in yogurt produce β-galactosidase that helps hydrolyse lactose during transit through the small intestine. Multiple RCTs since the 1980s show yogurt with live cultures causes less breath hydrogen and symptoms than the equivalent lactose load from milk or from heat-killed yogurt. EFSA approved the health claim in 2010 for products with ≥10^8 CFU/g of both organisms. Effect is consistent and clinically meaningful for the ~65% of adults worldwide with reduced lactase activity.
Bottom line: Reach for live-culture yogurt or kefir rather than milk if you're lactose-intolerant. EFSA-endorsed, multiply replicated.
Antibiotic-associated diarrhoea (AAD) prevention
Supplement benefitCochrane 2017 meta-analysis (33 RCTs, n=6,352 children) found probiotics reduced AAD incidence by ~55% (RR 0.45) with moderate-certainty evidence, with the best results at doses ≥5 × 10^9 CFU/day. S. thermophilus appears as one component in many of the studied multi-strain products (often with L. acidophilus and B. lactis). Single-strain S. thermophilus alone has limited direct AAD evidence; the benefit credit largely goes to the blend. ESPGHAN gives the strongest specific recommendations to L. rhamnosus GG and S. boulardii.
Bottom line: Multi-strain probiotic products containing S. thermophilus help prevent AAD in children. Effect is from the blend, not the strain alone.
Evidence is mixed
The single-strain S. thermophilus evidence is weaker than the multi-strain product evidence. Attribute the benefit to the blend, not S. thermophilus specifically.
Acute infectious diarrhoea in children
Disease adjunctESPGHAN/ESPID guidelines for acute gastroenteritis in children give the strongest single-strain recommendations to L. rhamnosus GG and S. boulardii. S. thermophilus features in some multi-strain combination products with supportive but more limited stand-alone evidence. Where supported, the typical effect is shortening diarrhoea duration by about a day. Probiotic use should NOT delay oral rehydration, which remains first-line.
Bottom line: Adjunct to oral rehydration, not a substitute. L. rhamnosus GG and S. boulardii have the strongest single-strain evidence.
Necrotising enterocolitis (NEC) prevention in preterm infants
Disease adjunctSome NICU probiotic protocols for preterm neonates use multi-strain products containing S. thermophilus alongside Bifidobacterium species. Meta-analyses show probiotic prophylaxis reduces NEC incidence and mortality in preterm infants. WGO and several neonatology bodies recognise probiotic use as reasonable in this setting, though strain selection is debated and product quality control is critical given the vulnerability of the population. This is strictly a NICU/neonatology decision under specialist care, not a parent-initiated supplement.
Bottom line: NICU-only use under specialist care. Not a parent-initiated supplement.
IBS / functional bowel symptoms in adults (general gut support)
Mechanism onlySingle-strain S. thermophilus has not been shown to reliably improve IBS symptoms or general 'gut health' in adults. Multi-strain probiotic products that include S. thermophilus have a mixed evidence base — some symptom improvement in some trials, but heterogeneity is high and effects are small. WGO and current IBS guidelines treat probiotics as a 'consider, but uncertain' option rather than a recommended therapy.
Bottom line: Don't pay a premium for single-strain S. thermophilus pills for general gut health. Choose live-culture yogurt for lactose digestion, or a well-studied multi-strain product for specific indications.
How to take it
What to track
Bottom line: For lactose intolerance, choose live-culture yogurt and eat it with your meal. For AAD prevention in kids, multi-strain probiotics that include S. thermophilus are reasonable. Single-strain S. thermophilus pills are overkill for general gut use.
3 commercial forms
Compare the main delivery options and what they’re best suited for.
Live-culture yogurt or kefir
Most evidence-backedFermented dairy with live S. thermophilus + L. bulgaricus (and often additional probiotic strains in kefir or 'probiotic yogurt' products). The format with the strongest evidence — directly endorsed by an EFSA health claim for lactose digestion. Look for 'live and active cultures' on the label.
Bacteria are alive and metabolically active in transit; β-galactosidase aids lactose hydrolysis directly.
Multi-strain probiotic capsule
Combination productsCapsule with S. thermophilus alongside Lactobacillus acidophilus, Bifidobacterium lactis/longum, and other strains. Most paediatric AAD-prevention trials use multi-strain blends. Typical total dose: 1–10 billion CFU/day. Choose products tested in published trials.
Quality and viability vary; require refrigeration unless specifically formulated shelf-stable.
Single-strain S. thermophilus capsule
Limited evidenceLess common. Direct clinical evidence for single-strain S. thermophilus is thin beyond lactose digestion. If you want probiotic capsule support, multi-strain products generally have a better evidence base.
Similar viability concerns; less data on clinical outcomes than multi-strain products.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Rare invasive infections (bacteraemia, endocarditis, central-line associated infections) reported in immunocompromised, critically ill, and central-line patients with various probiotic strains including streptococci. Don't use live probiotics in these populations without specialist input.
Probiotic capsule quality varies widely — some commercial products have been found to contain different organisms or fewer live CFUs than labelled. Choose third-party-tested brands.
Who should avoid it
- Severely immunocompromised people (chemotherapy-induced neutropenia, advanced HIV/AIDS, recent solid-organ or stem-cell transplant) — risk of probiotic-derived bacteraemia.
- People with central venous catheters or other long-term indwelling lines — case reports of catheter-related bloodstream infections.
- Critically ill ICU adults — recent trials and guidelines urge caution; routine probiotic supplementation in ICU is not recommended.
- People with active short bowel syndrome, recent GI surgery with anastomotic leak, or severely disrupted intestinal barrier — speak with your gastroenterologist first.
Pregnancy & breastfeeding
Live yogurt and kefir in normal food amounts are safe in pregnancy and breastfeeding. Standalone probiotic capsules at typical doses (1–10 billion CFU/day) appear safe in healthy pregnant women based on small RCTs, but stronger long-term data is limited — discuss with your obstetrician before starting high-dose multi-strain products.
Bottom line: Very safe in healthy adults and children eating yogurt or taking standard probiotic capsules. Avoid live probiotics in immunocompromised, ICU, and central-line patients without specialist sign-off.
Interactions
Risk of probiotic-derived bacteraemia during neutropenia. Most oncology centres ask patients to pause live probiotic supplements through chemo cycles.
Antibiotics may kill live probiotic bacteria when taken at the same time. Separate doses by at least 2 hours to give probiotics a chance to establish. The combination is INTENDED in AAD prevention — just space them out.
Reduced immune containment of probiotic bacteria; rare reports of invasive infection. Discuss with the prescriber before starting live probiotic supplements.
Case reports of probiotic-associated catheter bloodstream infections. Avoid live probiotic capsules; live yogurt is generally fine if you have no other risk factors.
Food sources
| Food | Amount | %DV |
|---|---|---|
| Live-culture plain yogurt | 1 cup / 245 g (≥10^9 CFU S. thermophilus + L. bulgaricus when labelled live) | — |
| Greek yogurt (strained, live-culture) | 1 cup / 200 g (similar CFU when labelled live and active) | — |
| Kefir | 1 cup / 240 mL (10–30 strains; typically 10^9–10^10 CFU total) | — |
| Skyr (Icelandic yogurt) | 1 cup / 200 g (live cultures when labelled) | — |
| Probiotic-fortified buttermilk | 1 cup / 240 mL (variable CFU depending on brand) | — |
Live-culture plain yogurt
- Amount
- 1 cup / 245 g (≥10^9 CFU S. thermophilus + L. bulgaricus when labelled live)
- %DV
- —
Greek yogurt (strained, live-culture)
- Amount
- 1 cup / 200 g (similar CFU when labelled live and active)
- %DV
- —
Kefir
- Amount
- 1 cup / 240 mL (10–30 strains; typically 10^9–10^10 CFU total)
- %DV
- —
Skyr (Icelandic yogurt)
- Amount
- 1 cup / 200 g (live cultures when labelled)
- %DV
- —
Probiotic-fortified buttermilk
- Amount
- 1 cup / 240 mL (variable CFU depending on brand)
- %DV
- —
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
References by claim
Lactose maldigestion / intolerance
Antibiotic-associated diarrhoea (AAD) prevention
Necrotising enterocolitis (NEC) prevention in preterm infants
World Gastroenterology Organisation, 2023 — WGO Global Guidelines — Probiotics and Prebiotics (2023) link
Acute infectious diarrhoea in children
Guarino et al. (ESPGHAN/ESPID), 2014 — Journal of Pediatric Gastroenterology and Nutrition (2014) link
Safety
Doron & Snydman, 2015 — Clinical Infectious Diseases (2015) link
Track Streptococcus Thermophilus with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.